APA (7th ed.) Citation

Cha, D., Gleeson, E., Shaltiel, T., Berger, Y., Macfie, R., Golas, B., . . . Cohen, N. (2021). Initial pancreatic ductal adenocarcinoma tumor resectability status is associated with early distant recurrence after neoadjuvant therapy followed by resection. HPB (1365-182X), 23, S592. https://doi.org/10.1016/j.hpb.2021.06.264

Chicago Style (17th ed.) Citation

Cha, D., E. Gleeson, T. Shaltiel, Y. Berger, R. Macfie, B. Golas, U. Sarpel, D. Labow, and N. Cohen. "Initial Pancreatic Ductal Adenocarcinoma Tumor Resectability Status Is Associated with Early Distant Recurrence After Neoadjuvant Therapy Followed by Resection." HPB (1365-182X) 23 (2021): S592. https://doi.org/10.1016/j.hpb.2021.06.264.

MLA (9th ed.) Citation

Cha, D., et al. "Initial Pancreatic Ductal Adenocarcinoma Tumor Resectability Status Is Associated with Early Distant Recurrence After Neoadjuvant Therapy Followed by Resection." HPB (1365-182X), vol. 23, 2021, p. S592, https://doi.org/10.1016/j.hpb.2021.06.264.